Amy Wagers seeks to change the way we repair our tissues after an injury. Her research focuses on defining the factors and mechanisms that regulate the migration, expansion, and regenerative potential of adult blood-forming and muscle-forming stem cells.
Joyce is the Core Facility Manager for the department’s Flow Cytometry Core Facility. She carries out fluorescence-activated cell sorting (FACS) and analysis for scientists using the facility, and is the contact for Core training and scheduling.
Sahar obtained her Ph.D. in Molecular and Developmental Biology from the National University of Singapore in Paul Matsudaira’s lab. Since 2015, Sahar has been working jointly as a postdoc in the Wagers Lab and the Zon Lab. She is interested in increasing the engraftment efficiency of transplanted muscle cells in the recipients. Outside of the lab, Sahar enjoys painting, swimming, and eating foods from around the world!
Jordan’s research uses genetic platforms and sequencing approaches to better understand how noncoding regions and RNA molecules function in regenerative contexts (hematopoietic and stem cells) and in the etiology of human disease.
Ozge is interested in understanding the molecular mechanism of hematopoietic stem cell (HSC) function. She did her Ph.D. at EMBL (Italy) and Heidelberg University on the mechanism of how first HSCs in the mouse embryo emerge. Afterward, she worked on human HSCs and patient-derived induced pluripotent stem cells to understand the underlying mechanism of hematological diseases. Currently, in Wagers lab, her postdoctoral project is on the regulation of HSC expansion, self-renewal, and differentiation in the adult mouse.
Naftali Horwitz graduated with a B.S. in Molecular and Cellular Biology from Johns Hopkins University in 2016. His studies center around stem cell maintenance and tissue regeneration in the context of aging.
Krystynne is from West Virginia and joined the Wagers lab from the Johns Hopkins Bloomberg School of Public Health, where she completed her Masters studies in biochemistry and molecular biology. She is currently examining the effects of GDF11 and its effects on aging and regeneration.
Bryan received an A.B. in Human Developmental and Regenerative Biology at Harvard in 2018. He was an Amgen Scholar at the National Institute of Allergy and Infectious Diseases and a Peer Study Leader in the Harvard Department of Chemistry and Chemical Biology. Bryan’s research focuses on genome editing, viral-mediated gene therapy, and Duchenne muscular dystrophy.
Michael Shadpour is an undergraduate researcher pursuing his A.B degree in Chemical and Physical Biology at Harvard. He is interested in the fundamental biology of aging and is currently investigating mechanisms to rejuvenate aged muscle stem cells. Michael also enjoys spending time with friends, powerlifting, and world travel.